News
Key findings highlight the therapeutic potential of cytokine-targeted biologics, Janus kinase (JAK) inhibitors, and emerging strategies such as miRNA modulation and engineered cytokines. Autoimmunity ...
TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, announced today that ...
2d
Investor's Business Daily on MSNBristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With ItBristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.
A team of researchers from the Rice Biotech Launch Pad at Rice University in Houston developed the implantable “cytokine ...
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, ...
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...
SGLT2 inhibitors are medications designed to help manage blood sugar in people living with type 2 diabetes. Learn more about the different types, as well as the benefits and side effects.
During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company's management team are scheduled to participate in ...
In addition to a greater risk for serious infection, patients with atopic dermatitis initiating JAK inhibitors vs Th2 cytokine inhibitors had a greater risk of Candida infections and a slightly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results